Works in JNCI: Journal of the National Cancer Institute, 2023, Vol 115, Issue 6
Results: 29
Correction to: Randomized trial of First-Line tyrosine kinase inhibitor with or without radiotherapy for synchronous oligometastatic EGFR-Mutated Non-Small cell lung cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 773, doi. 10.1093/jnci/djad084
- Publication type:
- Article
Correction to: ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 770, doi. 10.1093/jnci/djad077
- Publication type:
- Article
Correction to: COVID-19 severity by vaccination status in the NCI COVID-19 and Cancer Patients Study (NCCAPS).
- Published in:
- 2023
- Publication type:
- Correction Notice
Making sense of the risks: what to tell adolescents and young adults diagnosed with cancer during pregnancy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 603, doi. 10.1093/jnci/djad066
- By:
- Publication type:
- Article
RE: HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 762, doi. 10.1093/jnci/djad060
- By:
- Publication type:
- Article
Reply to Bertucci, De Nonneville, and Finetti.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 764, doi. 10.1093/jnci/djad059
- By:
- Publication type:
- Article
Reply to Li and Colleagues.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 760, doi. 10.1093/jnci/djad057
- By:
- Publication type:
- Article
RE: Heterozygous BRCA1 and BRCA2 and mismatch repair gene pathogenic variants in children and adolescents with cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 757, doi. 10.1093/jnci/djad056
- By:
- Publication type:
- Article
Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children's Oncology Group.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 733, doi. 10.1093/jnci/djad055
- By:
- Publication type:
- Article
Response to Song.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 768, doi. 10.1093/jnci/djad054
- By:
- Publication type:
- Article
Risk prediction of hepatitis B or C or HIV among newly diagnosed cancer patients.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 703, doi. 10.1093/jnci/djad053
- By:
- Publication type:
- Article
Design of phase II oncology trials evaluating combinations of experimental agents.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 613, doi. 10.1093/jnci/djad052
- By:
- Publication type:
- Article
Overcoming the challenges to implementation of artificial intelligence in pathology.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 608, doi. 10.1093/jnci/djad048
- By:
- Publication type:
- Article
RE: COVID-19 severity by vaccination status in the NCI COVID-19 and Cancer Patients Study (NCCAPS).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 766, doi. 10.1093/jnci/djad045
- By:
- Publication type:
- Article
Adverse birth outcomes of adolescent and young adult women diagnosed with cancer during pregnancy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 619, doi. 10.1093/jnci/djad044
- By:
- Publication type:
- Article
Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 712, doi. 10.1093/jnci/djad043
- By:
- Publication type:
- Article
Linear association between radioactive iodine dose and second primary malignancy risk in thyroid cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 695, doi. 10.1093/jnci/djad040
- By:
- Publication type:
- Article
Smoking as a prognostic factor for survival in patients with disseminated germ cell cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 753, doi. 10.1093/jnci/djad039
- By:
- Publication type:
- Article
Hysterectomy, bilateral oophorectomy, and breast cancer risk in a racially diverse prospective cohort study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 662, doi. 10.1093/jnci/djad038
- By:
- Publication type:
- Article
Use of menopausal hormone therapy and ovarian cancer risk in a French cohort study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 671, doi. 10.1093/jnci/djad035
- By:
- Publication type:
- Article
Historical redlining and breast cancer treatment and survival among older women in the United States.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 652, doi. 10.1093/jnci/djad034
- By:
- Publication type:
- Article
Medicaid expansion, chemotherapy delays, and racial disparities among women with early-stage breast cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 644, doi. 10.1093/jnci/djad033
- By:
- Publication type:
- Article
Characteristics of patient navigation programs in the Cancer Moonshot ACCSIS colorectal cancer screening initiative.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 680, doi. 10.1093/jnci/djad032
- By:
- Publication type:
- Article
Racial disparities in diagnostic evaluation of uterine cancer among Medicaid beneficiaries.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 636, doi. 10.1093/jnci/djad027
- By:
- Publication type:
- Article
The association of Medicaid expansion and pediatric cancer overall survival.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 749, doi. 10.1093/jnci/djad024
- By:
- Publication type:
- Article
Changes in survival in de novo metastatic cancer in an era of new medicines.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 628, doi. 10.1093/jnci/djad020
- By:
- Publication type:
- Article
Expression of Concern to: Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 769, doi. 10.1093/jnci/djac065
- Publication type:
- Article
Should We Target Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer With Radiotherapy Before Administering Targeted Systemic Therapy?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 605, doi. 10.1093/jnci/djac016
- By:
- Publication type:
- Article
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 742, doi. 10.1093/jnci/djac015
- By:
- Publication type:
- Article